Home Cart Sign in  
Chemical Structure| 17912-87-7 Chemical Structure| 17912-87-7

Structure of Myricetrin
CAS No.: 17912-87-7

Chemical Structure| 17912-87-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Myricitrin, a flavonoid compound isolated from the root bark of Myrica cerifera, which exerts antinociceptive effects.

Synonyms: Myricitrin; Myricitroside; NSC 19803

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Krueger, Nadine ; Kronenberger, Thales ; Xie, Hang ; Rocha, Cheila ; Poehlmann, Stefan ; Su, Haixia , et al.

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has forced the development of direct-acting antiviral drugs due to the coronavirus disease 2019 (COVID-19) pandemic. The main protease of SARS-CoV-2 is a crucial enzyme that breaks down polyproteins synthesized from the viral RNA, making it a validated target for the development of SARS-CoV-2 therapeutics. New chem. phenotypes are frequently discovered in natural goods. In the current study, we used a fluorogenic assay to test a variety of natural products for their ability to inhibit SARS-CoV-2 Mpro. Several compounds were discovered to inhibit Mpro at low micromolar concentrations It was possible to crystallize robinetin together with SARS-CoV-2 Mpro, and the X-ray structure revealed covalent interaction with the protease's catalytic Cys145 site. Selected potent mols. also exhibited antiviral properties without cytotoxicity. Some of these powerful inhibitors might be utilized as lead compounds for future COVID-19 research.

Keywords: COVID-19 ; antivirals ; coronavirus ; covalent drugs ; dynamic light scattering ; inhibitors ; main protease ; natural products

Alternative Products

Product Details of Myricetrin

CAS No. :17912-87-7
Formula : C21H20O12
M.W : 464.38
SMILES Code : O=C1C(O[C@H]2[C@@H]([C@@H]([C@H]([C@H](C)O2)O)O)O)=C(C3=CC(O)=C(O)C(O)=C3)OC4=CC(O)=CC(O)=C14
Synonyms :
Myricitrin; Myricitroside; NSC 19803
MDL No. :MFCD00016930
InChI Key :DCYOADKBABEMIQ-OWMUPTOHSA-N
Pubchem ID :5281673

Safety of Myricetrin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Myricetrin

epigenetics
GPCR

Isoform Comparison

Biological Activity

Target
  • PKCα

In Vitro:

Cell Line
Concentration Treated Time Description References
Human gingival fibroblasts 10 μM 4 h To study the effect of myricetin on LTA-induced COX-2 transcription and translation, it was found that myricetin significantly inhibited COX-2 expression. Cell Mol Biol Lett. 2014 Mar;19(1):126-39.
Human gingival fibroblasts 10 μM 30 min To evaluate the effects of myricetin on LTA-induced phosphorylation of ERK1/2, p38, and AKT, it was found that myricetin inhibited the activation of these kinases. Cell Mol Biol Lett. 2014 Mar;19(1):126-39.
Normal pancreatic ductal cells 12.5–200µM 24 h Myricetin had little effect on normal pancreatic ductal cell viability, except at the highest dose (200µM) Cancer Lett. 2011 Sep 28;308(2):181-8.
S2-013 cells 12.5–200µM 24 h Myricetin significantly reduced S2-013 cell viability in a dose-dependent manner Cancer Lett. 2011 Sep 28;308(2):181-8.
Panc-1 cells 12.5–200µM 24 h Myricetin significantly reduced Panc-1 cell viability in a dose-dependent manner Cancer Lett. 2011 Sep 28;308(2):181-8.
MIA PaCa-2 cells 12.5–200µM 24 h Myricetin significantly reduced MIA PaCa-2 cell viability in a dose-dependent manner Cancer Lett. 2011 Sep 28;308(2):181-8.
Rat islet cells 20 μM 48 h Myricetin significantly attenuated HG-induced apoptosis in isolated rat islets. Diabetes Metab J. 2019 Apr;43(2):192-205.
INS-1 cells 20 μM 24 h Myricetin protects INS-1 cells from HG-induced apoptosis by inhibiting ER stress, possibly through inactivation of CDK5 and consequent upregulation of PDX1 and SERCA2b. Diabetes Metab J. 2019 Apr;43(2):192-205.
C4-2B cells 20.6 ± 0.9 μM 3 days To evaluate the effect of myricetin on the growth of C4-2B cells, results showed that myricetin significantly reduced cell viability. J Biomed Sci. 2022 May 9;29(1):29.
LNCaP cells 18.5 ± 0.8 μM 3 days To evaluate the effect of myricetin on the growth of LNCaP cells, results showed that myricetin significantly reduced cell viability. J Biomed Sci. 2022 May 9;29(1):29.
THP1 macrophages 100, 200, 400 μM Evaluate the anti-inflammatory effect of Myricetin, results showed Myricetin significantly reduced the expression levels of RIPK1 and NF-κB. Phytomedicine. 2023 Jul 25;116:154858.
Vero E6 cells 1.95 to 31.25 μM 72 h Evaluate the inhibitory effect of Myricetin on SARS-CoV-2 replication, results showed EC50 of 55.18 μM. Phytomedicine. 2023 Jul 25;116:154858.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.15mL

0.43mL

0.22mL

10.77mL

2.15mL

1.08mL

21.53mL

4.31mL

2.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories